PON1 55/192 polymorphism, oxidative stress, type, prognosis and severity of stroke

IUBMB Life

Volumn 58, Issue 3, 2006, Pages 165-172

  Aydin, Makbule ^a   Gencer, Mehmet ^b   Cetinkaya, Yilmaz ^b   Ozkok, Elif ^a   Ozbek, Zeynep ^c   Kilic, Gamze ^d   Orken, Cihat ^b   Tireli, Hulya ^b   Kara, Ihsan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c Eyup State Hospital   (Turkey)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Glutathione reductase; Malondialdehyde; Paraoxonase activity; Paraoxonase genotypes; Prognosis; Severity; Stroke

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; GLUTATHIONE REDUCTASE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EMBOLISM; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION MAPPING; STATISTICAL SIGNIFICANCE; STROKE;

AGED; AMINO ACID SUBSTITUTION; ARGININE; ARYLDIALKYLPHOSPHATASE; CEREBROVASCULAR ACCIDENT; FEMALE; GLUTAMINE; HUMANS; LEUCINE; MALE; METHIONINE; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 33646884220     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540600688462     Document Type: Article

References (43)

1. Chan, P. H. (1994) Oxygen radicals in focal cerebral ischemia. Brain Pathol. 4, 59.
2. Braughler, J. M., and Hall, E. D. (1989) Central nervous system trauma and stroke: biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radical. Biol. Med. 6, 289-301.
3. Sharpe, P. C., Mulholland, C., and Trinick, T. (1994) Ascorbate and malondialdehyde in stroke patients. Int. J. Med. Sci. 163, 488-491.
4. Reed, D. J. (1990) Glutathione: toxicological implications. Ann. Rev. Pharmacol. Toxicol. 30, 603-631.
5. Mariano, S., Tomas, M., Eloosua, R., and Marrugat, J. (2000) Interrelationship of serum paraoxonase activity and paraoxonase genetic variants on atherosclerosis risk. Contrib. Sci. 1, 323-329.
6. Mackness, M. I., Mackness, B., Durrington, P. N., Connelly, P. W., and Hegele, R. A. (1996) Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr. Opin. Lipidol. 7, 69-76.
7. Adkins, S., Gan, K. N., Mody, M., and La Du, B. N. (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for respective A or B alloenzymes. Am. J. Hum. Genet. 52, 598-608.
8. Humbert, R., Adler, D. A., Disteche, C. M., Hasset, C., Omieecinki, C. J., and Furlong, C. E. (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3, 73-76.
9. Mackness, B., Mackness, M. I., Arrol, S., Turkie, W., and Durrington, P. N. (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high-density lipoprotein against low-density lipoprotein oxidative modification. FEES Lett. 423, 57-60.
10. Boerwinkle, E., Doris, P. A., and Fornage, M. (1999) Field of nees: the genetic of stroke. Circulation 99, 331-333.
11. Ueno, T., Shimazaki, E., Matsumoto, T., Watanabe, H., Tsunemi, A., Takahashi, Y., Mori, M., Hamano, R., Fujioka, T., Soma, M., Matsumoto, K., and Kanmatsuse, K. (2003) Paraoxonase1 polymorphism Leu-Met 55 is associated with cerebral infarction in Japanese population. Med. Sci. Monit. 9. CR260-264.
12. Voetsch, B., Benke, K. S., Damasceno, B. P., Siqueira, L. H., and Loscalzo J. (2002) Paraoxonase 192 Gln-Arg polymorphism. An independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 33, 1459-1464.
13. Oram, J. F. (1986) Receptor-mediated transport of cholesterol between cultured cells and high-density lipoproteins. Methods Enzymol. 129, 645-659.
14. Heinecke, J. W., and Lusis, A. J. (1998) Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis? Am. J. Hum. Genet. 62, 20-24.
15. Imre, S. G., Fekete, I., and Farkas, T. (1994) Increased proportion of docosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke 25, 2416-2420.
16. Cherubini, A., Polidori, M. C., Bregnonchi, M., Pezzuto, S., Cecchetti, R., Ingegni, T., di Iorio, A., Senin, U., and Mecocci, P. (2000) Antioxidant profile and early outcome in stroke patients. Stroke 31, 2295-2300.
17. Demirkaya, S., Topcuoglu, M. A., Aydin, A., Ulas, U. H., Isimer, A. I., and Vural, O. (2001) Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur. J. Neurol. 8, 43-51.
18. World Health Organization (WHO) (1997) Obesity: preventing and managing the global epidemic. Report of WHO Consultation on Obesity. Geneva, Switzerland.
19. Dabkin, B. H., and Thompson, A. J. (2000) Principles of neurological rehabilitation. In Neurology in Clinical Practice (Bradley, W. G., Daroff, R. B., Fenichel, G. M., and Marsden, C. D., eds). pp. 959-1005, USA.
20. Miller, S. A., Dykes, D. D., and Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
21. Furlong, C. E., Richter, R. J., Seidel, S. L., Costa, L. G., and Motulsky, A. G. (1989) Spectrophotometric assay for enzymatic hydrolysis of the active metabolites of chloropyrites and parathion by plasma paraoxonase/ arylesterase. Anal. Biochem. 80, 242-247.
22. Okhawa, H., Ohisi, N., and Yagi, K. (1979) Assay for lipid peroxides in animal tissues by TBA reaction. Anal. Biochem. 95, 351-358.
23. Goldberg, D. M., and Spooner, R. J. (1983) In methods of enzymatic analysis. In (Bergmeyen, H. V., ed.), pp. 258-265, Verlog Chemie, Deerfield Beach, FL.
24. Hassan, A., and Markus, H. S. (2000) Genetics and ischemic stroke. Brain 123, 1784-1812.
25. Humphries, S. E., and Morgan, L. (2004) Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gen approaches. Lancet Neurol. 3, 227-236.
26. Schmidt, R., Schmidt, H., Fazekas, F., Kapeller, P., Roob, G., Lechner, A., Kostner, G. M., and Hartung, H. P. (2000) MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms: three-year follow-up of the Austrian Stroke prevention study. Arterioscler. Thromb. Vasc. Biol. 20, 1811-1816.
27. Schmidt, H., Schmidt, R., Niederkorn, K., Gradert, A., Schumacher, M., Watzinger, N., Hartung, H. P., and Kostner, G. M. (1998) Paraoxonase PON1 polymorphism Leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 29, 2043-2048.
28. Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C., and La Du, B. (1998) Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler. Thromb. Vasc. Biol. 18, 1617-1624.
29. Saha, A., Adak, S., Chowdhury, S., and Bhattacharyya, M. (2005) Enhanced oxygen releasing capacity and oxidative stress in diabetes mellitus and diabetes mellitus-associated cardiovascular disease: a comparative study. Clin. Chim. Acta 361, 141-149.
30. Serrato, M., and Marian, A. J. (1995) A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J. Clin. Invest. 96, 3005-3008.
31. Fuhrman, B., Judith, O., Keidar, S., Ben-Yaish, L., Kaplan, M., and Aviram, M. (1997) Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radic. Biol. Med. 23, 34-46.
32. Chang, C. Y., Lai, Y. C., Cheng, T. J., Lau, M. T., and Hu, M. L. (1998) Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic stroke patients as compared to matched controls in Taiwan. Free Radic. Res. 28, 15-24.
33. Leinonen, J. S., Ahonen, J. P., and Lönnrot, K. (2000) Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 31, 33-39.
34. Spranger, M., Krempien, S., Schwab, S., Donneberg, S., and Hacke, W. (1997) Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Stroke 28, 2425-2428.
35. Zimmermann, C., Winnefeld, K., Streck, S., Roskos, M., and Haberl, R. L. (2004) Antioxidant status in acute stroke patients and patients at stroke risk. Eur. Neurol. 51, 157-161.
36. Poulet, R., Gentile, M. T., Vecchione, C., Distaso, M., Aretini, A., Fratta, L., Russo, G., Echart, C., Maffei, A., De Simoni, M. G., and Lembo, G. (2006) Acute hypertension induces oxidative stress in brain tissues. J. Cereb. Blood Flow Metab. 26, 253-262.
37. Zaltzberg, H., Kanter, Y., Aviram, M., and Levy, Y. (1999) Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM. Isr. Med. Assoc. J. 1, 228-231.
38. Krouf, D., Bouchenak, M., Mohammedi, B., Cherrad, A., Belleville, J., and Prost, J. (2003) Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects. Med. Sci. Monit. 9, 109-115.
39. Schnackenberg, C. G., Welch, W. J., and Wilcox, C. S. (1998) Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32, 59-64.
40. Mackness, B., Mackness, M. I., Arrol, S., Turkie, W., and Durrington, P. N. (1997) Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br. J. Pharma. 112, 265-268.
41. Polidori, M. C., Frei, B., Cherubini, A., Nelles, G., Keaney, J. F. Jr, Schwamm, L., Mecocci, P., Koroshetz, W. J., and Beal, M. F. (1998) Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic. Biol. Med. 25, 561-567.
42. Soong, C. (1993) Free radical production and lipid peroxidation during femoral popliteal bypass grafting. Eur. J. Vasc. Surg. 7, 540-545.
43. Cao, H., Girard-Globba, A., Berthezene, F., and Moulin, P. (1999) Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q R genetic polymorphism. J. Lipid Res. 40, 133-139.